184 related articles for article (PubMed ID: 20937111)
1. The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma.
Li L; Zhang C; Li X; Lu S; Zhou Y
J Exp Clin Cancer Res; 2010 Oct; 29(1):133. PubMed ID: 20937111
[TBL] [Abstract][Full Text] [Related]
2. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.
Li LW; Li YY; Li XY; Zhang CP; Zhou Y; Lu SH
BMC Cancer; 2011 Feb; 11():52. PubMed ID: 21288367
[TBL] [Abstract][Full Text] [Related]
3. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
4. [Tumor-suppressing function of human esophageal cancer related gene 4 in esophageal squamous cell carcinoma].
Li LW; Yang Y; Li XY; Guo LP; Zhou Y; Lu SX
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2713-7. PubMed ID: 21162904
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.
Li W; Liu X; Zhang B; Qi D; Zhang L; Jin Y; Yang H
J Exp Clin Cancer Res; 2010 Jul; 29(1):89. PubMed ID: 20598162
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
8. UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma.
Li L; Li X; Wang W; Gao T; Shi Z
Biomed Pharmacother; 2018 Feb; 98():201-206. PubMed ID: 29268240
[TBL] [Abstract][Full Text] [Related]
9. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma.
Feng J; Qi B; Guo L; Chen LY; Wei XF; Liu YZ; Zhao BS
World J Gastroenterol; 2017 Jun; 23(23):4243-4251. PubMed ID: 28694664
[TBL] [Abstract][Full Text] [Related]
10. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
Li LW; Yu XY; Li XY; Guo LP; Zhou Y; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):570-3. PubMed ID: 22325214
[TBL] [Abstract][Full Text] [Related]
12. Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells.
Matsuzaki J; Torigoe T; Hirohashi Y; Tamura Y; Asanuma H; Nakazawa E; Saka E; Yasuda K; Takahashi S; Sato N
Pathol Int; 2013 Aug; 63(8):391-7. PubMed ID: 23957914
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.
Zhang R; Chen X; Zhang S; Zhang X; Li T; Liu Z; Wang J; Zang W; Wang Y; Du Y; Zhao G
Dig Dis Sci; 2015 May; 60(5):1247-55. PubMed ID: 25480402
[TBL] [Abstract][Full Text] [Related]
14. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
15. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
16. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
Mao Y; Liu J; Zhang D; Li B
Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
[TBL] [Abstract][Full Text] [Related]
17. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
[TBL] [Abstract][Full Text] [Related]
18. Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.
Li L; Wang W; Li X; Gao T
Am J Transl Res; 2017; 9(8):3741-3748. PubMed ID: 28861165
[TBL] [Abstract][Full Text] [Related]
19. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
[TBL] [Abstract][Full Text] [Related]
20. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
He Z; Chen J; Chen X; Wang H; Tang L; Han C
J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
